Essilorluxottica ADR ESLOY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ESLOY is a good fit for your portfolio.
News
-
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase— Update
-
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase
-
France's CDC Increases Stake in EssilorLuxottica, Il Sole24 Ore Reports
-
Kering, EssilorLuxottica Among Bidders for Eyewear Maker Marcolin, the Financial Times Reports
-
Sunglass Hut Announces New, First-Of-Its-Kind Loyalty Program
-
Correction to EssilorLuxottica Article
-
EssilorLuxottica, Moncler Sign Exclusive Licensing Agreement
-
EssilorLuxottica Upbeat on Mid-Term Targets Despite Slowing Growth
Trading Information
- Previous Close Price
- $111.44
- Day Range
- $112.09–113.33
- 52-Week Range
- $84.17–115.51
- Bid/Ask
- $112.97 / $113.37
- Market Cap
- $104.63 Bil
- Volume/Avg
- 10,419 / 33,704
Key Statistics
- Price/Earnings (Normalized)
- 30.08
- Price/Sales
- 3.74
- Dividend Yield (Trailing)
- 1.91%
- Dividend Yield (Forward)
- 1.91%
- Total Yield
- 2.14%
Company Profile
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 36% of sales in Europe, 47% in North America, and the rest in Asia and Latin America.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 200,000
- Website
- https://www.essilorluxottica.com
Competitors
Valuation
|
Metric
|
ESLOY
|
COO
|
|---|---|---|
Price/Earnings (Normalized) | 30.08 | 27.92 |
Price/Book Value | 2.44 | 2.40 |
Price/Sales | 3.74 | 5.05 |
Price/Cash Flow | 17.83 | 21.43 |
Price/Earnings
ESLOY
COO
Financial Strength
|
Metric
|
ESLOY
|
COO
|
|---|---|---|
Quick Ratio | 0.63 | 0.81 |
Current Ratio | 1.00 | 1.86 |
Interest Coverage | 15.90 | 4.77 |
Quick Ratio
ESLOY
COO
Profitability
|
Metric
|
ESLOY
|
COO
|
|---|---|---|
Return on Assets (Normalized) | 4.87% | 2.49% |
Return on Equity (Normalized) | 7.79% | 3.88% |
Return on Invested Capital (Normalized) | 6.03% | 3.63% |
Return on Assets
ESLOY
COO
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Ybwqfgmh | Gjkg | $136.3 Bil | |
BDX
| Becton Dickinson & Co | Clhymzt | Ctdqy | $67.9 Bil | |
ALC
| Alcon Inc | Wsxfplw | Gkvbfh | $43.4 Bil | |
RMD
| ResMed Inc | Jnpygmvtff | Vznzvj | $31.7 Bil | |
CLPBY
| Coloplast A/S ADR | Tfvlfyfvph | Zszp | $27.2 Bil | |
WST
| West Pharmaceutical Services Inc | Jfgtzvdnqr | Jwcsp | $26.2 Bil | |
COO
| The Cooper Companies Inc | Rrcnlvzh | Wcgrpg | $19.1 Bil | |
BAX
| Baxter International Inc | Qdpxpzgy | Zjwdqpk | $18.0 Bil | |
HOLX
| Hologic Inc | Mknqkzlb | Hsvgby | $17.7 Bil | |
ATR
| AptarGroup Inc | Dljhxcsxs | Nmmqdv | $9.8 Bil |